<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171215037872N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-07-13</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Efficacy of Repetitive Transcranial Magnetic Stimulation to Reduce Muscle Spasticity</public_title>
      <acronym></acronym>
      <scientific_title>Efficacy of Repetitive Transcranial Magnetic Stimulation to Reduce Muscle Spasticity in Patients with Traumatic Brain Injury</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28480</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Random assignment method In this study, the method of the permutation block will be such that A represents the person receiving the intervention and B represents the person who does not receive the intervention. This method, taking into account the six-membered blocks so that the total number of possible quadrupole permutations is equal to 4, includes: AABB, ABAB, BABA, BBAA. Then, with Using the random numbers table and assigning the code from 0 to 9 to each permutation, (randomized list of 60) (considering the drop in patients from the study), which includes 15 blocks of 4 (60 * 4 * 60 total number of samples ) And the order of assignment of each method to each of the participating samples is determined.
For example: (ABAB Code 0, AABB Code 1, BABA Code 2, BBAA Code 3 to 9)
Then, using the random numbers table, the starting point is selected randomly and 15 randomly selected (row or column) is selected and the assigned permutation is written to each number. (The order of placing permutations next to each other is left to right respectively) and how all 60 people will be assigned to the two groups A and B, Blinding description: The control group was studied by the coil off of the sham stimulation device.
The patient's examiner who evaluates spasticity is not aware of the lack or existence of the device .</study_design>
      <phase>N/A</phase>
      <hc_freetext>Spasticity in traumatic brain injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Includes 20 traumatic brain injury patients who are eligible for the study and randomly selected. The motor cortex is determined by a coil of the 8th form of magnetic stimulation. Prior to that, the threshold of motion of the intervertebral muscles of the back of the other side is determined. The lowest single pulse intensity is tms with a stimulated motor potential of 50 millivolts, determined by EMG. The following magnetic stimulation is applied as follows: Frequency: 1 Hz / pulse number: 1500 / intensity: 90% of the motor threshold Each person receives a TMS meeting for 10 days a day. Intervention 2: Control group: Twenty traumatic traumatic brain injury patients who were eligible for the study were randomly selected. The control group was studied by the coil off of the sham stimulation study.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is After the data is collected and interventions are conducted on how to publish the decision. In case of publication in a newspaper article, the publisher decides on how to publish</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sharareh Roshanzamir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>16th floor,Gole narges building,  Shahid Goodarzi street,Shahid Rajaee Blvd.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7184839113</zip>
        <telephone>+98 71 3230 5410</telephone>
        <email>sharareh.roshanzamir@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sharareh Roshanzamir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>16th floor,Gole narges building,  Shahid Goodarzi street,Shahid Rajaee Blvd.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7184839113</zip>
        <telephone>+98 71 3230 5410</telephone>
        <email>sharareh.roshanzamir@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age over 18 and under 75 years
presence of muscle spasticity at grades 3 and 4 in at least one of the muscle compartments
With muscle_ power grading over 3</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of ischemic  or hemorrhage stroke and multiple sclerosis
Existence of joint dryness and adhesion
Major fractures and history of cerebral cranial surgeries in the past
positive history of  cardiac arrhythmias
positive history of brain aneurysm or seizure (focal or generalized)
history of surgery involving metal or clips implants
unstable Vital signs
Chronic Pain</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S06.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diffuse traumatic brain injury</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Includes 20 traumatic brain injury patients who are eligible for the study and randomly selected. The motor cortex is determined by a coil of the 8th form of magnetic stimulation. Prior to that, the threshold of motion of the intervertebral muscles of the back of the other side is determined. The lowest single pulse intensity is tms with a stimulated motor potential of 50 millivolts, determined by EMG. The following magnetic stimulation is applied as follows: Frequency: 1 Hz / pulse number: 1500 / intensity: 90% of the motor threshold Each person receives a TMS meeting for 10 days a day.</i_keyword>
      <i_keyword>Control group: Twenty traumatic traumatic brain injury patients who were eligible for the study were randomly selected. The control group was studied by the coil off of the sham stimulation study.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Muscle tone. Timepoint: The beginning of the study, before and after each intervention, one month after the end of the interventions. Method of measurement: Data collection is done through the Modified Ashworths Scale to evaluate the muscle tone that points to 0 to 4 for the patient's examination.</prim_outcome>
      <prim_outcome>Power of muscle. Timepoint: The beginning of the study, before and after each intervention, one month after the end of the interventions. Method of measurement: Using the MRC Score based on the range of patient's movement, the score is 0-5.</prim_outcome>
      <prim_outcome>Activity of daily living. Timepoint: The beginning of the study, before and after each intervention, one month after the end of the interventions. Method of measurement: The score for Barthel's score is 0-100 based on the patient's daily activity.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-11-14</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Fifth Floor, Central Building of Shiraz University, Jomhuory Boulevard Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
